Shenzhen Bioeasy Biotechnology Co Ltd
SZSE:300942
Shenzhen Bioeasy Biotechnology Co Ltd
SZSE:300942
Price:
8.26
CNY
-3.17%
Market Closed
Market Cap:
¥3.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Shenzhen Bioeasy Biotechnology Co Ltd
SZSE:300942
|
CN |
|
Volvo Car AB
STO:VOLCAR B
|
SE |
|
Pritish Nandy Communications Ltd
NSE:PNC
|
IN |
|
Hebei Sinopack Electronic Technology Co Ltd
SZSE:003031
|
CN |
|
H
|
Hybrid Technologies Co Ltd
TSE:4260
|
JP |
|
U
|
Universal Music Group NV
OTC:UMGNF
|
NL |
|
Azure Minerals Ltd
ASX:AZS
|
AU |
|
F
|
Fullsun International Holdings Group Co Ltd
HKEX:627
|
HK |
|
Metarock Group Ltd
ASX:MYE
|
AU |
|
O
|
Orion Office Reit Inc
NYSE:ONL
|
US |
|
Novartis AG
NYSE:NVS
|
CH |
|
New Zealand Energy Corp
XTSX:NZ
|
NZ |
|
China CSSC Holdings Ltd
SSE:600150
|
CN |
|
Suzumo Machinery Co Ltd
TSE:6405
|
JP |
|
T
|
Test Rite International Co Ltd
TWSE:2908
|
TW |
|
China Mobile Ltd
HKEX:941
|
CN |
|
Visionary Education Technology Holdings Group Inc
NASDAQ:GV
|
CA |
|
Planet Fitness Inc
NYSE:PLNT
|
US |
Multiples-Based Value
The Multiples-Based Value of one
Shenzhen Bioeasy Biotechnology Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 8.26 CNY,
Shenzhen Bioeasy Biotechnology Co Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Shenzhen Bioeasy Biotechnology Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Shenzhen Bioeasy Biotechnology Co Ltd Competitors
Shenzhen Bioeasy Biotechnology Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Shenzhen Bioeasy Biotechnology Co Ltd
SZSE:300942
|
3.3B CNY | 13.2 | 106.1 | 100.4 | 100.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
10T JPY | 10.9 | 39.8 | 28.9 | 34.7 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.7B CHF | 3.6 | 38.4 | 14.8 | 28.7 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
37.1B USD | 0 | 0 | 0 | 0 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
94.9B DKK | 3.5 | 24.6 | 13 | 15.5 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.5B USD | 3.1 | 30.1 | 12.9 | 17.8 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.5 | 34.6 | 12 | 18.7 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
937.4B JPY | 7.2 | 53 | 25.1 | 34.2 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.8B USD | 1.1 | -16.2 | 17.2 | 55.7 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
38.9B CNY | 4 | 22.9 | 34.1 | 34.1 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
36.4B CNY | 8 | 22.1 | 19.7 | 19.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
